IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression.
about
Host immune response to infection and cancer: unexpected commonalitiesCancer therapy using a self-replicating RNA vaccineThe future of interleukin-2: enhancing therapeutic anticancer vaccinesInterleukin-12 is capable of generating an antigen-specific Th1-type response in the presence of an ongoing infection-driven Th2-type response.Interleukin-12 synthesis is a required step in trehalose dimycolate-induced activation of mouse peritoneal macrophages.The Ikaros transcription factor regulates responsiveness to IL-12 and expression of IL-2 receptor alpha in mature, activated CD8 T cells.Interleukin-12 is critical for induction of nitric oxide-mediated immunosuppression following vaccination of mice with attenuated Salmonella typhimurium.Developing recombinant and synthetic vaccines for the treatment of melanoma.The new vaccines: building viruses that elicit antitumor immunity.Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccineImmunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.Toll-like receptors in tumor immunotherapy.T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient miceCostimulation enhances the active immunotherapy effect of recombinant anticancer vaccines.Construction and characterization of a triple-recombinant vaccinia virus encoding B7-1, interleukin 12, and a model tumor antigen.Immunotherapy of cancer by IL-12-based cytokine combinationsTransfectant influenza A viruses are effective recombinant immunogens in the treatment of experimental cancerInterleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model.Cytokines in cancer immunotherapy.Genetically engineered poxviruses for recombinant gene expression, vaccination, and safetyTherapeutic efficacy of PD-L1 blockade in a breast cancer model is enhanced by cellular vaccines expressing B7-1 and glycolipid-anchored IL-12.Oncolytic virus therapy for cancer.Genetic Adjuvantation of Recombinant MVA with CD40L Potentiates CD8 T Cell Mediated Immunity.Tune Up In Situ Autovaccination against Solid Tumors with Oncolytic Viruses.
P2860
Q27015410-21540369-193A-4981-A962-B4F5F2EA1791Q27481056-EE990CE5-0528-4D44-A9C3-9BB7E29B7F3AQ33844221-733704DC-D5E4-4CB5-B32D-30D2C2B80E6AQ33866879-8D60D536-5578-47B4-9D68-CEE54369149AQ34423291-CEE28E55-982A-4660-9477-75AA435F45E4Q34618230-84E55332-91A0-4218-A9E1-1B3C1D31EB51Q35559415-74AC54B3-022C-4F10-8889-4C98D63F4FF0Q35946196-4B367DB6-B345-42E6-8BFF-511804187F14Q35946203-827E55FA-A7B5-46CA-8922-86279A06091CQ36082419-AB0D5588-4D16-4586-B1FB-696D401C1ECCQ36119828-D617A4C0-49B4-44DB-8646-D2A6924099B0Q36253608-D2481297-2F0C-4051-AA9A-1E92E048006BQ36367817-CE3F0C43-0F8A-453D-AF54-35F53B94FA47Q36470722-50D37B85-0CA4-4B0F-B16C-9594FB386B9CQ36473821-8A4119B8-2147-4E0F-81AF-E312B7F36EEDQ36724827-BDBD5590-76E2-4141-91C4-D38301B799F6Q36916492-8445B47E-A79E-4DA2-BDCD-75EFC2064398Q36925312-952E4DEE-B75B-41D6-9B39-9E0D318EACDFQ37148152-A41E388D-51D8-468A-A762-2AE5CFA9A34FQ37249251-1224FE13-B3D3-40B6-812C-D6FFDE561CEBQ37309250-21EC1394-6A59-4884-9BF8-13E72181B22BQ38924529-E4E8AE1A-855C-4077-B949-92325865E1F1Q41822355-0A2C2AD2-EF5A-481C-BC55-983F54C50821Q55509278-4132E083-726C-40BC-B5D9-620DE8E2F6F7
P2860
IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
IL-12 is an effective adjuvant ...... simultaneous B7-1 expression.
@ast
IL-12 is an effective adjuvant ...... simultaneous B7-1 expression.
@en
type
label
IL-12 is an effective adjuvant ...... simultaneous B7-1 expression.
@ast
IL-12 is an effective adjuvant ...... simultaneous B7-1 expression.
@en
prefLabel
IL-12 is an effective adjuvant ...... simultaneous B7-1 expression.
@ast
IL-12 is an effective adjuvant ...... simultaneous B7-1 expression.
@en
P2093
P2860
P1476
IL-12 is an effective adjuvant ...... y simultaneous B7-1 expression
@en
P2093
K R Irvine
M W Carroll
N P Restifo
R S Chamberlain
S A Rosenberg
P2860
P304
P407
P577
1996-05-01T00:00:00Z